MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517021810 A) filed by Enliven Inc., Boulder, U.S.A., on March 11, for 'naphthyridine compounds for inhibition of raf kinases.'
Inventor(s) include Lyssikatos Joseph P; Ren Li; and Kintz Samuel.
The application for the patent was published on May 16, under issue no. 20/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to compounds and compositions for inhibition of RAF serine/threonine protein kinases methods of preparing said compounds and compositions and their use in the treatment of various cancers."
The patent application was internationally filed on Aug. 24, 2023, under International...